Hsbc Holdings PLC Buys Shares of 688,707 Stryker Corporation $SYK

Hsbc Holdings PLC purchased a new stake in shares of Stryker Corporation (NYSE:SYK) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund purchased 688,707 shares of the medical technology company’s stock, valued at approximately $216,432,000. Hsbc Holdings PLC owned about 0.18% of Stryker at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Gables Capital Management Inc. acquired a new position in shares of Stryker during the second quarter worth $25,000. Kilter Group LLC bought a new stake in shares of Stryker during the second quarter worth about $25,000. Godfrey Financial Associates Inc. acquired a new position in shares of Stryker in the fourth quarter valued at approximately $26,000. Sankala Group LLC bought a new position in Stryker in the 4th quarter valued at approximately $26,000. Finally, Compass Financial Management LLC acquired a new stake in Stryker during the 2nd quarter worth approximately $27,000. Institutional investors own 77.09% of the company’s stock.

Stryker Price Performance

Shares of SYK opened at $331.06 on Wednesday. The firm has a market cap of $126.98 billion, a PE ratio of 34.31, a price-to-earnings-growth ratio of 2.09 and a beta of 0.76. Stryker Corporation has a 52-week low of $281.00 and a 52-week high of $396.86. The business’s 50 day moving average price is $327.80 and its two-hundred day moving average price is $331.95. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 earnings per share for the quarter, beating the consensus estimate of $3.49 by $0.20. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The company had revenue of $6.59 billion during the quarter, compared to analyst estimates of $6.58 billion. During the same quarter in the previous year, the business posted $3.13 EPS. Stryker’s revenue for the quarter was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, equities analysts anticipate that Stryker Corporation will post 15.02 EPS for the current year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a $0.88 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 annualized dividend and a yield of 1.1%. Stryker’s dividend payout ratio is presently 36.48%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. Weiss Ratings reissued a “hold (c)” rating on shares of Stryker in a report on Friday, July 31st. BTIG Research cut their price target on shares of Stryker from $371.00 to $358.00 and set a “buy” rating on the stock in a report on Friday, July 31st. Citigroup reissued a “buy” rating on shares of Stryker in a research note on Thursday, August 13th. Wall Street Zen upgraded Stryker from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Finally, Evercore set a $350.00 target price on Stryker in a research report on Monday, July 6th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, Stryker presently has a consensus rating of “Moderate Buy” and a consensus target price of $386.28.

Insider Buying and Selling at Stryker

In related news, insider Debra King sold 826 shares of the stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total value of $277,783.80. Following the transaction, the insider directly owned 6,210 shares in the company, valued at $2,088,423. This trade represents a 11.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Ronda E. Stryker sold 50,000 shares of the business’s stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $340.10, for a total transaction of $17,005,000.00. Following the sale, the director owned 2,251,375 shares of the company’s stock, valued at $765,692,637.50. This trade represents a 2.17% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 355,370 shares of company stock valued at $119,447,201. Company insiders own 4.60% of the company’s stock.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.